Three commercial indirect enzyme-linked immunosorbent assays (ELISAs) (Enzygnost-Rubella, RUBE-LISA, and ORTHO Rubella) were evaluated for the determination of immune status by testing 1,090 serum specimens, 410 of which were from nonimmune patients. In comparison with the standard reference technique, the hemagglutination inhibition (HAI) test, the sensitivities of ORTHO Rubella (100%) and MATERIALS AND METHODS Clinical specimens. The study materials consisted of serum specimens from 1,090 pregnant women (680 sera were from immune patients and 410 sera were from susceptible patients as determined by HAI). The sera tested were submitted mainly by hospitals, pathologists, and medical practitioners in New South Wales for routine antenatal testing. The sera were initially tested by HAI and then stored at -20°C for no longer than 10 months until subsequent testing by the three ELISA systems.
Rubella is usually a relatively mild exanthematous illness in children or adults. Infection of women in early pregnancy may result in congenital abnormalities of the fetus. The control of rubella infection in Australia is being attempted by routine vaccination of schoolgirls aged 10 to 14 years and selected immunization of nonpregnant seronegative women of childbearing age (13) . Accurate determination of the immune status of women of childbearing age and diagnosis of recent infection in pregnant women are of paramount importance.
The hemagglutination inhibition (HAI) test has been considered the standard procedure for diagnosis of rubella infection and evaluation of immune status (17) . This test shows excellent correlation for protection to the fetus with the more cumbersome and technically difficult neutralization test (12) , which some regard as the ultimate standard. However, the HAI test is time-consuming, the incomplete removal of nonspecific inhibitors and agglutinins (7) can diminish its accuracy, and standardization between laboratories is difficult. For these reasons 
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Clinical specimens. The study materials consisted of serum specimens from 1,090 pregnant women (680 sera were from immune patients and 410 sera were from susceptible patients as determined by HAI). The sera tested were submitted mainly by hospitals, pathologists, and medical practitioners in New South Wales for routine antenatal testing. The sera were initially tested by HAI and then stored at -20°C for no longer than 10 months until subsequent testing by the three ELISA systems.
The range of serum samples studied was purposely skewed toward seronegative and low-positive levels, because the aim of an immunity screening test is to detect susceptible individuals. Furthermore, previous works in this laboratory (unpublished) and elsewhere (3, 18, 22) have shown that discrepancies tend to occur with sera containing low levels of HAI antibodies.
HAI All systems used an anti-human IgG conjugate; this conjugate was polyclonal with the RUBELISA and EnzygnostRubella systems, but the ORTHO Rubella system used a monoclonal anti-human IgG (murine) highly specific for the Fc portion of the heavy chain of human IgG (10 Table 3 . This comparison showed good correlation (r 2 0.94) between HAI titers, after transformation to natural logs, and the corresponding ELISA mean absorbance values. All three ELISA absorbance values were found to increase proportionately with increasing HAI titers; thus, the antibody levels determined by the ELISAs reflect HAI titers.
Precision. The results showed a high degree of reproducibility for each ELISA system. For the RUBELISA system, the coefficients of variation were 8.1 and 9.1 for the highpositive and low-positive sera, respectively, for the intraassay and 10.0 and 9.6, respectively, for the interassay; for the Enzygnost system, the coefficients of variation for the highpositive and low-positive sera were 5.6 and 5.9, respectively, for the intraassay and 8.4 and 9.8, respectively, for the interassay. For the ORTHO Rubella system the corresponding coefficients of variation were 6.2 and 6.5, respectively, for the intraassay and 9.8 and 9.2, respectively, for the interassay. DISCUSSION Although ELISA methods are potentially more sensitive than HAI tests, little is known about the clinical significance (i.e., the protective immunity) of low levels of antibody which may be detected in HAI-negative sera by ELISA (11) . Therefore, rubella ELISA tests are calibrated to correlate with the currently accepted standard, the HAI test. This correlation has been the aim of the manufacturers of the three ELISA systems evaluated in the current study.
While not absolutely accurate in some hands (2) , the HAI test is the best approximation for immunity at present, and in (8) .
The three ELISA systems showed good agreement with the HAI test and were found to be simple, rapid, and economical alternatives. The only disagreement in sensitivity was observed with sera having HAI titers of 10 and 20. Whereas the ORTHO Rubella and Enzygnost-Rubella systems showed excellent sensitivities compared with the HAI test, the RUBELISA system was marginally less satisfactory. In some cases, it was apparent that the lack of sensitivity of the RUBELISA system may be attributed to an elevated absorbance value of the control antigen well relative to the absorbance value of the antigen well. The correlation curve of ELISA absorbance versus log of HAI titer (data not shown) had the most gradual slope for the RUBELISA system, reflecting the lower sensitivity of this system in comparison with the Enzygnost-Rubella and ORTHO Rubella systems, whose correlation curves had steeper slopes. However, because of individual serum absorbances scattering around the mean and overlapping multiple HAI values, the ELISA value of a single serum should not be used to report an equivalent HAI titer. Hence, ELISA results from clinical laboratories should be accompanied by an interpretative comment.
All three ELISA systems achieved excellent specificity. An explanation for the discrepant sera, which all had positive reactions very close to the absorbance cutoff point, may be that both the ORTHO Rubella and RUBELISA systems have had their cut-off points between immunity and susceptibility calibrated to correlate with an HAI test cutoff titer of 8, whereas our in-house HAI test has a marginally higher cutoff titer of 10. To minimize the occurrence of false low-positive results in the ORTHO Rubella system, one of two modifications could be incorporated. First, those sera with standardized ELISA values in the range from 0.20 to 0.25 could be regarded as equivocal, and second, the results must be confirmed by a different procedure. The There have been few independent reports of the evaluation of commercial reagent sets for rubella IgG by micro-ELISA methods. The study reported herein is an in-depth and comprehensive comparative evaluation of three such reagent sets. Previous individual studies (3, 8, 18, 22) have shown that the RUBELISA system has a specificity of 99 to 100%, but sensitivity ranged from 91.4 to 67.7%, which was attributed, in the main, to the lack of detection of some sera with HAI titers of 10 and 20. All these published studies show that while specificity is excellent sensitivity is lacking. A new rapid ELISA that overcomes this lack of sensitivity with low-HAI-titer sera has been reported (1) .
These three assays use markedly contrasting configurations (Table 3) . Cutoff absorbance levels were fixed in the Enzygnost-Rubella system, compared with the floating threshold in others, which is more tolerant of interlaboratory variation. This assay also does not have a negative control serum, which may lead to a failure to detect inadequate washing. Control antigens have been used to detect nonspecific binding in the Enzygnost-Rubella and RUBELISA systems (6), whereas highly purified antigen, as used in the ORTHO Rubella system, bypasses the need for such controls (19, 21) .
Heat-treated sera, used in concurrent complement fixation tests or to inactivate infectious human immunodeficiency virus (16) , were satisfactory substrates for the RUBELISA and ORTHO systems but not for the Enzygnost-Rubella system, as found with some other ELISA systems (14, 15) . The heated sera show increased reactivity with control antigen wells, often above the cutoff, but the reason for this reactivity is not known (9; P. W. Robertson, personal communication).
In conclusion, on the basis of the present study, we would prefer to use either the Enzygnost-Rubella or the ORTHO Rubella system rather than the RUBELISA system instead of the time-consuming HAI test for the determination of immune status, provided that (i) sera for testing in the Enzygnost-Rubella system must not have been heat inactivated and (ii) for the ORTHO system, standardized ELISA values in the range from 0.20 to 0.25 should be regarded as equivocal unless confirmed by a different procedure.
